Skip to main content

MindMaze Therapeutics Holding SA

MMTZF
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001854078

No open-market purchases or sales by MindMaze Therapeutics Holding SA insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $19 in total; no superinvestor holds it.

Other share classesRLFTY

Q4 2023 vs. Q3 2023

How the institutions holding MindMaze Therapeutics Holding SA changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of MMTZF: Q3 2023 compared with Q4 2023
MeasureQ3 2023Q4 2023Change
Holders110
Shares11712−105 (−89.7%)
Value$293$28−$265 (−90.4%)

New holders (1)

Institutions that held MindMaze Therapeutics Holding SA at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to MMTZF in Q4 2023
InstitutionSharesValue% of portfolio
Strategic Investment Solutions, Inc.12$280.00%

Sold out (1)

Institutions that held MindMaze Therapeutics Holding SA at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of MMTZF in Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
Cornerstone Planning Group LLC117$293